Christos Georgalas

About

Christos Georgalas is a leading otolaryngologist and researcher whose work centers on advancing surgical treatments for obstructive sleep apnoea (OSA) and oropharyngeal cancer. His primary contributions lie in evaluating the safety, efficacy, and quality-of-life outcomes of transoral robotic surgery (TORS) for complex patient populations. Notably, his 2017 study on TORS as a multilevel treatment for obese OSA patients who failed conventional therapy demonstrated a 50% success rate—a critical breakthrough for a cohort with life-threatening disease and no alternative but tracheostomy. This work, cited 18 times, highlights his focus on high-risk, treatment-refractory patients. More recently, his 2024 meta-analysis comparing TORS to primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma (15 citations) provides pivotal evidence on functional outcomes, while his 2025 meta-analysis on sleep and quality-of-life outcomes in OSA (2 citations) further solidifies his impact. Georgalas’s research bridges surgical innovation with patient-centered metrics, offering hope to those with limited options. His work is essential reading for clinicians and researchers exploring minimally invasive solutions in head and neck surgery and sleep medicine.

Research Focus

Key Achievements

Top Papers

1. 1
   Is transoral robotic surgery a safe and effective multilevel treatment for obstructive sleep apnoea in obese patients following failure of conventional treatment(s)?

   18 citations · 2017
2. 2
   Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis

   15 citations · 2024
3. 3
   Quality of Life and Sleep Outcomes in Obstructive Sleep Apnoea Following Transoral Robotic Surgery: A Meta‐Analysis

   2 citations · 2025

Key Collaborators

Contact & Links